NYSE:SYK Stryker (SYK) Stock Price, News & Analysis $371.50 +1.25 (+0.34%) (As of 03:22 PM ET) Add Compare Share Share Today's Range$370.01▼$374.6350-Day Range$315.94▼$370.1752-Week Range$249.98▼$374.63Volume442,361 shsAverage Volume1.29 million shsMarket Capitalization$141.57 billionP/E Ratio42.41Dividend Yield0.86%Price Target$378.58 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Get Stryker alerts: Email Address Stryker MarketRank™ Stock AnalysisAnalyst RatingModerate Buy2.79 Rating ScoreUpside/Downside1.9% Upside$378.58 Price TargetShort InterestHealthy1.24% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.95Upright™ Environmental ScoreNews Sentiment0.63Based on 24 Articles This WeekInsider TradingSelling Shares$68.33 M Sold Last QuarterProj. Earnings Growth12.08%From $12.00 to $13.45 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.74 out of 5 starsMedical Sector50th out of 927 stocksSurgical & Medical Instruments Industry9th out of 101 stocks 2.4 Analyst's Opinion Consensus RatingStryker has received a consensus rating of Moderate Buy. The company's average rating score is 2.79, and is based on 15 buy ratings, 4 hold ratings, and no sell ratings.Amount of Analyst CoverageStryker has been the subject of 11 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Stryker's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted1.24% of the float of Stryker has been sold short.Short Interest Ratio / Days to CoverStryker has a short interest ratio ("days to cover") of 3.7, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Stryker has recently increased by 18.67%, indicating that investor sentiment is decreasing significantly. Previous Next 3.3 Dividend Strength Dividend YieldStryker has a dividend yield of 0.87%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthStryker has been increasing its dividend for 31 years.Dividend CoverageThe dividend payout ratio of Stryker is 36.53%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Stryker will have a dividend payout ratio of 23.79% next year. This indicates that Stryker will be able to sustain or increase its dividend.Read more about Stryker's dividend. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreStryker has received a 60.46% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "Neurostimulators", "Protective clothing", "Synthetic bone grafts", "Surgery simulation software", "Medical laboratory equipment", and "Bone cement" products. See details.Environmental SustainabilityThe Environmental Impact score for Stryker is -0.95. Previous Next 2.0 News and Social Media Coverage News SentimentStryker has a news sentiment score of 0.63. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 24 news articles for Stryker this week, compared to 12 articles on an average week.Search InterestOnly 10 people have searched for SYK on MarketBeat in the last 30 days. This is a decrease of -60% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Stryker to their MarketBeat watchlist in the last 30 days. This is a decrease of -75% compared to the previous 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Stryker insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $68,330,400.00 in company stock.Percentage Held by InsidersOnly 5.90% of the stock of Stryker is held by insiders.Percentage Held by Institutions77.09% of the stock of Stryker is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Stryker's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Stryker are expected to grow by 12.08% in the coming year, from $12.00 to $13.45 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Stryker is 42.41, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 131.73.Price to Earnings Ratio vs. SectorThe P/E ratio of Stryker is 42.41, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 136.21.Price to Earnings Growth RatioStryker has a PEG Ratio of 2.84. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioStryker has a P/B Ratio of 7.59. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Stryker's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTIFear of an impending recessionA lot of traders are worried about the threat of a recession… and with good reason. How can you guard against the worst case scenario? Use a tool that could see this collapse coming… Like my 10 AM Income Project. Back in July, the trading tool behind this 10 AM Income Project fired a serious warning signal… Even though NVDA was firing on all cylinders and every stock trader in the world seemed to want a piece, I saw the “red flag” because of these two lines…To discover how you could see the REAL crash BEFORE it starts, click here now. About Stryker Stock (NYSE:SYK)Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.Read More SYK Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart SYK Stock News HeadlinesSeptember 9, 2024 | marketbeat.comMedtronic Stock: Growth On Rise of the Cardiovascular Machines (SYK)Medtronic is a leading global medical device maker in the medical sector. Its innovative and critical medical device portfolio addresses chronic diseasesAugust 29, 2024 | insidertrades.comStryker Co. (NYSE:SYK) Insider Sells $213,000.00 in StockSeptember 16, 2024 | DTI (Ad)Massive shakeup in defense contractingThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.August 23, 2024 | marketbeat.comDiabetes and Neuro Products Ignite Medtronic’s Q1 Earnings RallyMedtronic's Q1 FY2025 results were driven by its diabetes products, and new offerings in development or pending FDA approval could fuel future performance.September 13 at 9:00 PM | markets.businessinsider.comStryker’s Growth Projection Bolstered by LIFEPAK 35 Launch: A Strong Buy RecommendationSeptember 12, 2024 | msn.comStryker - Growth Through Aggressive M&ASeptember 12, 2024 | prnewswire.comEko Health Announces Appointment of Brent Lang, Former CEO of Vocera, to Board of DirectorsSeptember 12, 2024 | americanbankingnews.comStryker (NYSE:SYK) Coverage Initiated at Wolfe ResearchSeptember 16, 2024 | DTI (Ad)Massive shakeup in defense contractingThere is a little-known energy technology stock that has made an incredible breakthrough… Which could become crucial to the operations of the US Military. And right now there are plans for this stock to undertake a major test project at a US Air Force based in Alaska. Now, this incredible breakthrough is still in its earliest stages… Which means you still have a chance to get in while its trading for under $10.September 11, 2024 | benzinga.comStryker Unveils New Foot & Ankle Solutions With Truss Implants: DetailsSeptember 11, 2024 | finance.yahoo.comStryker Expands Foot & Ankle Portfolio With Specialized Offerings Designed to Enhance Surgical Precision and OutcomesSeptember 11, 2024 | msn.comWolfe Research Initiates Coverage of Stryker (SYK) with Outperform RecommendationSeptember 11, 2024 | americanbankingnews.comStryker (NYSE:SYK) Given "Overweight" Rating at Piper SandlerSeptember 10, 2024 | finance.yahoo.comStryker Insiders Sell US$177m Of Stock, Possibly Signalling CautionSeptember 10, 2024 | markets.businessinsider.comStryker (SYK) Receives a Buy from Piper SandlerSeptember 10, 2024 | benzinga.comHere's How Much You Would Have Made Owning Stryker Stock In The Last 15 YearsSeptember 9, 2024 | markets.businessinsider.comWells Fargo Sticks to Their Buy Rating for Stryker (SYK)September 6, 2024 | seekingalpha.comStryker Corporation (SYK) Wells Fargo 2024 Healthcare Conference (Transcript)See More Headlines Receive SYK Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Stryker and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 7/31 Dividend6/28/2024Last Earnings7/30/2024Dividend Payable7/31/2024Today9/16/2024Ex-Dividend for 10/31 Dividend9/30/2024Dividend Payable10/31/2024Next Earnings (Estimated)11/07/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryHealth Care Equipment Current SymbolNYSE:SYK CUSIP86366710 CIK310764 Webwww.strykercorp.com Phone(269) 385-2600Fax269-385-1062Employees52,000Year Founded1941Price Target and Rating Average Stock Price Target$378.58 High Stock Price Target$406.00 Low Stock Price Target$345.00 Potential Upside/Downside+2.0%Consensus RatingModerate Buy Rating Score (0-4)2.79 Research Coverage19 Analysts Profitability EPS (Most Recent Fiscal Year)$8.76 Trailing P/E Ratio42.38 Forward P/E Ratio30.94 P/E Growth2.84Net Income$3.17 billion Net Margins16.12% Pretax Margin18.78% Return on Equity22.89% Return on Assets11.03% Debt Debt-to-Equity Ratio0.51 Current Ratio1.68 Quick Ratio0.95 Sales & Book Value Annual Sales$20.50 billion Price / Sales6.90 Cash Flow$13.54 per share Price / Cash Flow27.43 Book Value$48.94 per share Price / Book7.59Miscellaneous Outstanding Shares381,080,000Free Float358,474,000Market Cap$141.49 billion OptionableOptionable Beta0.91 Social Links 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesMr. Kevin A. Lobo (Age 59)Chairman, CEO & President Comp: $5.7MMr. Glenn S. Boehnlein (Age 62)VP & CFO Comp: $2.27MMr. Viju S. Menon (Age 56)Group President of Global Quality & Operations Comp: $1.68MMr. J. Andrew Pierce (Age 50)Group President of MedSurg & Neurotechnology Comp: $2.03MMr. Spencer S. Stiles (Age 47)Group President of Orthopaedics & Spine Comp: $2.02MMr. William E. Berry Jr. (Age 58)VP & Chief Accounting Officer Mr. Robert C. CohenCTO and VP of Global R&D - Joint ReplacementMr. Alan DouvilleVP, Chief Information Officer & Chief Information Security OfficerMr. Jason BeachVice President of Finance & Investor RelationsMr. Robert S. Fletcher (Age 53)VP & Chief Legal Officer Comp: $895.89kMore ExecutivesKey CompetitorsAbbott LaboratoriesNYSE:ABTIntuitive SurgicalNASDAQ:ISRGBoston ScientificNYSE:BSXMedtronicNYSE:MDTBecton, Dickinson and CompanyNYSE:BDXView All CompetitorsInsiders & InstitutionsAmerican TrustSold 819 shares on 9/12/2024Ownership: 0.004%Prio Wealth Limited PartnershipSold 19,761 shares on 9/10/2024Ownership: 0.001%Heritage Wealth Management Inc.Bought 3,575 shares on 9/9/2024Ownership: 0.001%Sanctuary Advisors LLCBought 57,509 shares on 9/5/2024Ownership: 0.015%Clear Rock Advisors LLCBought 140 shares on 9/3/2024Ownership: 0.003%View All Insider TransactionsView All Institutional Transactions Should I Buy Stryker Stock? SYK Pros and Cons Explained Pros Here are some ways that investors could benefit from investing in Stryker Co.: Stryker Co. has consistently shown strong financial performance with a solid return on equity of 22.89%, indicating efficient use of shareholder funds. The company has a diverse product portfolio across its MedSurg, Neurotechnology, and Orthopaedics and Spine segments, reducing dependency on any single market. Recent insider selling activities, including the CFO selling shares at $333.00, could indicate confidence in the company's future performance. Stryker Co. announced a quarterly dividend of $0.80 per share, reflecting a stable dividend payout ratio of 36.53% and a yield of 0.89% for investors seeking income. Analysts have given Stryker Co. an average rating of "Moderate Buy" with a target price of $373.84, suggesting potential upside for investors based on market expectations. Cons Investors should be bearish about investing in Stryker Co. for these reasons: The recent insider selling activities, with insiders selling a significant number of shares, may raise concerns about the company's future growth prospects. Stryker Co.'s stock price has been relatively stagnant, trading down 0.2% recently, which could indicate limited short-term price appreciation potential. The company's P/E ratio of 41.14 and price-to-earnings-growth ratio of 2.78 suggest that the stock may be currently overvalued compared to its growth prospects. While the company has a strong market capitalization of $137.35 billion, the beta of 0.89 indicates that the stock may be less volatile than the market average, potentially limiting potential returns for risk-seeking investors. Despite positive earnings results, Stryker Co. faces competition in the medical technology sector, which could impact its market share and profitability in the long term. These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, September 4, 2024. Please send any questions or comments about these Stryker pros and cons to contact@marketbeat.com. SYK Stock Analysis - Frequently Asked Questions How have SYK shares performed this year? Stryker's stock was trading at $299.46 on January 1st, 2024. Since then, SYK stock has increased by 24.1% and is now trading at $371.52. View the best growth stocks for 2024 here. How were Stryker's earnings last quarter? Stryker Co. (NYSE:SYK) announced its earnings results on Tuesday, July, 30th. The medical technology company reported $2.81 earnings per share for the quarter, beating analysts' consensus estimates of $2.79 by $0.02. The company's revenue was up 8.5% compared to the same quarter last year. Read the conference call transcript. Does Stryker have any subsidiaries? Stryker subsidiaries include these companies: Vocera Communications, Vocera, Gauss Surgical, OrthoSensor, Wright Medical Group, Cardan Robotics, Mobius Imaging, and others. Who are Stryker's major shareholders? Top institutional investors of Stryker include Bank of New York Mellon Corp (1.49%), First Western Trust Bank (0.92%), Legal & General Group Plc (0.75%) and Clearbridge Investments LLC (0.61%). Insiders that own company stock include Ronda E Stryker, Kevin Lobo, James Andrew Pierce, Allan C Golston, M Kathryn Fink, Viju Menon, Robert S Fletcher, Srikant M Datar, William E Berry Jr and Glenn S Boehnlein. View institutional ownership trends. How do I buy shares of Stryker? Shares of SYK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Stryker own? Based on aggregate information from My MarketBeat watchlists, some other companies that Stryker investors own include Johnson & Johnson (JNJ), Walt Disney (DIS), Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV) and Cisco Systems (CSCO). This page (NYSE:SYK) was last updated on 9/16/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | Sponsored44-year Wall Street Vet: “Permanent devastation is coming to America”After 44 years on Wall Street, I've seen it all... Black Monday, the Great Recession, the Covid crash. B...InvestorPlace | SponsoredBREAKING NEWS: AI Tech Now Used to Stop School ShootersTwo seconds. That's all it takes for Knightscope's Automated Gunshot Detection to notify authorities and map a...Market JAR | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredPrepare for a Recession Unlike Any OtherDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dav...American Hartford Gold Group | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredNvidia needs these 3 companies on a new $1 trillion SuperprojectNvidia is pivoting to a new $1 trillion Superproject that could revolutionize the AI industry… again. And i...Weiss Ratings | SponsoredTrump’s weapon lurks in abandoned AmericaUnemployment is sky-high, wages are at record lows. Addiction has overwhelmed these once thriving coal towns. ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Stryker Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Stryker With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.